Chenchen Qian

Dr. Chenchen Qian is a board-certified physician scientist at Mayo Clinic's Department of Internal Medicine in Phoenix, Arizona. With dual expertise in clinical medicine and research, she maintains active roles in patient care, particularly for hospitalized patients with complex medical conditions, while leading investigations in cancer biology and inflammatory diseases. Her professional journey spans institutions across the United States and China, reflecting a global perspective on medical research and practice.

Dr. Qian's educational background includes an MD from Zhongshan Medical School, Sun Yat-sen University (2010), PhD training in Gastroenterology and Internal Medicine at Sun Yat-sen Memorial Hospital (2015), a visiting research scholar position in Biochemistry and Molecular Biology at Mayo Clinic Rochester (2015), and Internal Medicine residency at University of Pittsburgh Medical Center (2022).

Her research interests span pancreatic and gastric cancer biology, targeted cancer therapies using nanomedicine approaches, inflammatory responses, NLRP3 inflammasome regulation, and critical care medicine. Recent work has focused on macrophage biology in acute lung injury, mechanisms of inflammatory diseases, and complications of viral infections including COVID-19. Her approach consistently bridges basic molecular mechanisms with clinical applications, demonstrating strong translational research capabilities.

Dr. Qian's publication record shows a progression from focused cancer biology research to broader investigations of inflammatory mechanisms and their clinical implications. Her work appears in high-impact journals across multiple disciplines, reflecting the interdisciplinary nature of her research.

• Board-certified by American Board of Internal Medicine (2022)

Dr. Qian maintains active collaborations across multiple institutions, including Mayo Clinic (multiple locations), University of Pittsburgh, Sun Yat-sen University in China, and international partners. Her work with the Stenosis Therapy and Antifibrotic Research (STAR) Consortium demonstrates her integration into broader research networks. While specific grant information isn't provided in the available materials, her continued publication in high-impact journals suggests active research funding supporting her investigations in cancer biology and inflammatory diseases.

Though no specific laboratory is mentioned, Dr. Qian's research activities span multiple domains including cancer biology, immunology, and critical care medicine, suggesting she likely collaborates with multiple research teams across Mayo Clinic's extensive research infrastructure. Her work on nanoparticle-based cancer therapies indicates experience with specialized laboratory techniques in drug delivery and molecular biology.